BAJAJ BROKING

Notification close image
No new Notification messages
card image
Indogulf Cropsciences IPO is Open!
Apply for the Indogulf Cropsciences IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

6220

532834

CAMLINFINE

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

CAMLIN FINE SCIENCES LTD performance

Today’s low

Today’s high

₹ 311.30 ₹ 326.99
₹ 313.80

52 week low

52 week high

₹ 93.40 ₹ 333.30
₹ 313.80

Open Price

₹ 322.00

Prev. Close

₹ 327.53

Volume (Shares)

323838.00

Total traded value

₹ 1016.20

Upper Circuit

₹ 343.90

Lower Circuit

₹ 311.15

info

CAMLIN FINE SCIENCES LTD Share Price Update

As of the latest trading session, CAMLIN FINE SCIENCES LTD share price is currently at ₹ 313.8, which is down by ₹ -13.73 from its previous closing. Today, the stock has fluctuated between ₹ 311.30 and ₹ 326.99. Over the past year, CAMLIN FINE SCIENCES LTD has achieved a return of 221.61 %. In the last month alone, the return has been 33.37 %. Read More...

Investment Returns

Over 1 Month 33.37% Over 3 Months 90.57% Over 6 Months 153.48% Over 1 Year 221.61%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

CAMLIN FINE SCIENCES LTD fundamentals


  • Market cap (Cr)

    5,897.00

  • P/E Ratio (TTM)

    -78.44

  • Beta

    1.48

  • Book Value / share

    45.88

  • Return on equity

    -7.57%

  • EPS (TTM)

    0.98

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    15.62

info icon alternate text
  • Market cap (Cr)

    5,895.10

  • P/E Ratio (TTM)

    -78.44

  • Beta

    1.38

  • Book Value / share

    45.88

  • Return on equity

    -7.57%

  • EPS (TTM)

    0.98

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    15.62

info icon alternate text

CAMLIN FINE SCIENCES LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 272.60
Operating Expense 269.90
Net Profit 15.62
Net Profit Margin (%) 5.73
Earnings Per Share (EPS) 0.86
EBITDA 42.47
Effective Tax Rate (%) -31.26
Particulars DEC 2024 (Values in Cr)
Revenue 205.07
Operating Expense 219.09
Net Profit -5.63
Net Profit Margin (%) -2.74
Earnings Per Share (EPS) -0.33
EBITDA 23.22
Effective Tax Rate (%) 21.83
Particulars SEP 2024 (Values in Cr)
Revenue 226.91
Operating Expense 244.26
Net Profit -72.62
Net Profit Margin (%) -32.00
Earnings Per Share (EPS) -4.34
EBITDA -79.18
Effective Tax Rate (%) 34.29
Particulars JUN 2024 (Values in Cr)
Revenue 181.91
Operating Expense 201.29
Net Profit -13.68
Net Profit Margin (%) -7.52
Earnings Per Share (EPS) -0.82
EBITDA 8.70
Effective Tax Rate (%) 22.27
Particulars MAR 2024 (Values in Cr)
Revenue 220.33
Operating Expense 272.64
Net Profit -44.07
Net Profit Margin (%) -20.00
Earnings Per Share (EPS) -2.65
EBITDA -22.01
Effective Tax Rate (%) 9.47
Particulars MAR 2025 (Values in Cr)
Revenue 886.49
Operating Expense 934.54
Net Profit -76.31
Net Profit Margin (%) -8.60
Earnings Per Share (EPS) -4.41
EBITDA -4.78
Effective Tax Rate (%) 38.17
Particulars MAR 2024 (Values in Cr)
Revenue 773.26
Operating Expense 849.85
Net Profit -51.39
Net Profit Margin (%) -6.64
Earnings Per Share (EPS) -3.09
EBITDA 44.08
Effective Tax Rate (%) 13.81
Particulars MAR 2023 (Values in Cr)
Revenue 789.44
Operating Expense 751.64
Net Profit 47.55
Net Profit Margin (%) 6.02
Earnings Per Share (EPS) 3.18
EBITDA 156.39
Effective Tax Rate (%) 28.62
Particulars MAR 2022 (Values in Cr)
Revenue 685.51
Operating Expense 668.14
Net Profit 25.87
Net Profit Margin (%) 3.77
Earnings Per Share (EPS) 1.98
EBITDA 96.19
Effective Tax Rate (%) 28.29
Particulars MAR 2021 (Values in Cr)
Revenue 600.05
Operating Expense 590.00
Net Profit 8.28
Net Profit Margin (%) 1.37
Earnings Per Share (EPS) 0.67
EBITDA 66.84
Effective Tax Rate (%) 44.87
Particulars MAR 2024 (Values in Cr)
Book Value / Share 48.76
ROE % -8.56
ROCE % 1.35
Total Debt to Total Equity 0.94
EBITDA Margin 6.15
Particulars MAR 2023 (Values in Cr)
Book Value / Share 47.88
ROE % 6.28
ROCE % 10.79
Total Debt to Total Equity 1.02
EBITDA Margin 13.02
Particulars MAR 2022 (Values in Cr)
Book Value / Share 42.17
ROE % 9.99
ROCE % 11.08
Total Debt to Total Equity 0.99
EBITDA Margin 13.51
Particulars MAR 2021 (Values in Cr)
Book Value / Share 38.75
ROE % 13.81
ROCE % 14.46
Total Debt to Total Equity 1.15
EBITDA Margin 16.16
Particulars MAR 2020 (Values in Cr)
Book Value / Share 32.97
ROE % 7.71
ROCE % 11.90
Total Debt to Total Equity 1.29
EBITDA Margin 13.21
Particulars MAR 2024 (Values in Cr)
Book Value / Share 42.54
ROE % -7.57
ROCE % 0.18
Total Debt to Total Equity 0.83
EBITDA Margin 6.67
Particulars MAR 2023 (Values in Cr)
Book Value / Share 40.67
ROE % 7.70
ROCE % 11.12
Total Debt to Total Equity 0.87
EBITDA Margin 20.50
Particulars MAR 2022 (Values in Cr)
Book Value / Share 37.52
ROE % 4.90
ROCE % 7.62
Total Debt to Total Equity 0.79
EBITDA Margin 14.46
Particulars MAR 2021 (Values in Cr)
Book Value / Share 32.59
ROE % 1.97
ROCE % 6.56
Total Debt to Total Equity 0.85
EBITDA Margin 11.78
Particulars MAR 2020 (Values in Cr)
Book Value / Share 30.80
ROE % 8.48
ROCE % 10.48
Total Debt to Total Equity 0.90
EBITDA Margin 14.47
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 93.53
Total Assets 1951.72
Total Liabilities 1951.72
Total Equity 856.95
Share Outstanding 167465207
Price to Book Ratio 2.10
Return on Assets (%) -4.75
Return on Capital (%) -6.12
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 99.22
Total Assets 2060.09
Total Liabilities 2060.09
Total Equity 824.08
Share Outstanding 157093496
Price to Book Ratio 3.13
Return on Assets (%) 2.52
Return on Capital (%) 3.25
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 142.13
Total Assets 1800.08
Total Liabilities 1800.08
Total Equity 765.05
Share Outstanding 156984246
Price to Book Ratio 3.72
Return on Assets (%) 3.37
Return on Capital (%) 4.37
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 138.34
Total Assets 1481.60
Total Liabilities 1481.60
Total Equity 713.15
Share Outstanding 127498471
Price to Book Ratio 4.29
Return on Assets (%) 3.43
Return on Capital (%) 4.24
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 64.78
Total Assets 1234.06
Total Liabilities 1234.06
Total Equity 460.10
Share Outstanding 121253996
Price to Book Ratio 1.28
Return on Assets (%) 2.45
Return on Capital (%) 3.19
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 13.95
Total Assets 1571.99
Total Liabilities 1571.99
Total Equity 715.71
Share Outstanding 167465207
Price to Book Ratio 2.10
Return on Assets (%) -3.26
Return on Capital (%) -4.26
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 9.82
Total Assets 1593.80
Total Liabilities 1593.80
Total Equity 642.14
Share Outstanding 157093496
Price to Book Ratio 3.13
Return on Assets (%) 2.98
Return on Capital (%) 3.82
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 56.47
Total Assets 1345.93
Total Liabilities 1345.93
Total Equity 592.34
Share Outstanding 156984246
Price to Book Ratio 3.72
Return on Assets (%) 1.92
Return on Capital (%) 2.49
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 81.58
Total Assets 1066.71
Total Liabilities 1066.71
Total Equity 464.63
Share Outstanding 127498471
Price to Book Ratio 4.29
Return on Assets (%) 0.77
Return on Capital (%) 0.99
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 13.12
Total Assets 891.34
Total Liabilities 891.34
Total Equity 376.80
Share Outstanding 121253996
Price to Book Ratio 1.28
Return on Assets (%) 3.44
Return on Capital (%) 4.34
Particulars MAR 2024 (Values in Cr)
Net Income -99.24
Cash from Operations 186.51
Cash from Investing -66.49
Cash from Financing -85.97
Net change in Cash -13.48
Free Cash Flow 247.09
Particulars MAR 2023 (Values in Cr)
Net Income 80.37
Cash from Operations 71.09
Cash from Investing -124.62
Cash from Financing 59.65
Net change in Cash -14.06
Free Cash Flow 215.40
Particulars MAR 2022 (Values in Cr)
Net Income 93.97
Cash from Operations 175.81
Cash from Investing -249.12
Cash from Financing 135.97
Net change in Cash 32.29
Free Cash Flow 389.60
Particulars MAR 2021 (Values in Cr)
Net Income 105.09
Cash from Operations 153.31
Cash from Investing -132.85
Cash from Financing 38.62
Net change in Cash 23.15
Free Cash Flow 237.18
Particulars MAR 2020 (Values in Cr)
Net Income 58.20
Cash from Operations 103.93
Cash from Investing -90.11
Cash from Financing 3.25
Net change in Cash -0.84
Free Cash Flow 238.07
Particulars MAR 2024 (Values in Cr)
Net Income -59.63
Cash from Operations 100.38
Cash from Investing -51.72
Cash from Financing -34.05
Net change in Cash -3.67
Free Cash Flow 141.38
Particulars MAR 2023 (Values in Cr)
Net Income 66.62
Cash from Operations 25.91
Cash from Investing -114.73
Cash from Financing 78.39
Net change in Cash -17.81
Free Cash Flow 157.10
Particulars MAR 2022 (Values in Cr)
Net Income 36.07
Cash from Operations 47.94
Cash from Investing -172.32
Cash from Financing 128.92
Net change in Cash 3.39
Free Cash Flow 237.43
Particulars MAR 2021 (Values in Cr)
Net Income 15.01
Cash from Operations 36.38
Cash from Investing -87.99
Cash from Financing 80.05
Net change in Cash 18.07
Free Cash Flow 75.92
Particulars MAR 2020 (Values in Cr)
Net Income 41.28
Cash from Operations 74.99
Cash from Investing -66.02
Cash from Financing -26.06
Net change in Cash -18.19
Free Cash Flow 190.10
Company Name Price P/E P/B Market Cap 52 Week Low/High
ATUL LTD 7402.10 45.03 3.89 21793.08 4882.00 / 8165.25
BASF INDIA LTD 5106.25 48.24 6.08 22102.73 4076.75 / 8748.10
ORIENTAL AROMATICS LTD 379.40 37.20 1.92 1276.82 252.40 / 656.00
DEEPAK FERTILIZERS & PETR 1594.95 21.57 3.22 20134.30 646.55 / 1635.20
Company Name Price P/E P/B Market Cap 52 Week Low/High
ADVANCE PETROCHEMICALS LTD. 193.60 57.62 4.41 17.42 171.00 / 330.00
ATUL LTD 7402.10 47.76 3.93 21793.08 4882.00 / 8165.25
BASF INDIA LTD 5106.25 46.76 6.04 22102.73 4076.75 / 8748.10
ORIENTAL AROMATICS LTD 379.40 27.26 1.88 1276.82 252.40 / 656.00

CAMLIN FINE SCIENCES LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
313.80 -4.19 redarrow
red-green-graph indicator
2 Bearish
14 Bullish
  • 5 Days 319.70
  • 26 Days 279.40
  • 10 Days 310.80
  • 50 Days 245.30
  • 12 Days 306.90
  • 100 Days 206.70
  • 20 Days 290.70
  • 200 Days 172.90
325.44 PIVOT

First Support

318.39

First Resistance

334.59

Second Support

309.24

Second Resistance

341.64

Third Support

302.19

Third Resistance

350.79

RSI

76.23

ADX

62.02

MACD

27.48

Williams % R

-10.07

Commodity Channel Index (CCI)

105.41

Date

2025-06-16

Week

965257.00

Same Day

908430.00

Month

1112368.00

1 Year

1.48

3 Year

1.04

Over 1 Month

33.37%

down

Over 1 Year

221.61%

down

Over 3 Months

90.57%

down

Over 3 Years

43.92%

down

Over 6 Months

153.48%

down

Over 5 Years

44.37%

down

CAMLIN FINE SCIENCES LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
45.6%
Promoter Holdings
49.09%
FII
1.46%
DII
3.82%
Promoter Shares(Pledge Percentage)
10.84%
Name Shares Category
Ashish Subhash Dandekar 1.977851E7 (10.52%) Shareholding of Promoter and Promoter Group
Infinity Direct Holdings 1.9556046E7 (10.41%) Shareholding of Promoter and Promoter Group
Anfima Nv 1.6968077E7 (9.03%) Shareholding of Promoter and Promoter Group
Infinity Holdings 1.1917407E7 (6.34%) Shareholding of Promoter and Promoter Group
Infinity Direct Holdings Sidecar I 9267239.0 (4.93%) Shareholding of Promoter and Promoter Group
Camart Finance Limited 5319360.0 (2.83%) Shareholding of Promoter and Promoter Group
Icici Prudential Smallcap Fund 5057894.0 (2.69%) Public Shareholding
Nirmal Vinod Momaya 3602270.0 (1.92%) Public Shareholding
Anagha Subhash Dandekar 3018549.0 (1.61%) Shareholding of Promoter and Promoter Group
Vibha Agencies Pvt Ltd 2606340.0 (1.39%) Shareholding of Promoter and Promoter Group
Ajay Upadhyaya 2450000.0 (1.3%) Public Shareholding
Infinity Portfolio Holdings 2246355.0 (1.2%) Shareholding of Promoter and Promoter Group
Jagdish N Master 2026000.0 (1.08%) Public Shareholding
Urjita J Master 2026000.0 (1.08%) Public Shareholding
Cafco Consultants Limited 1497600.0 (0.8%) Shareholding of Promoter and Promoter Group
Radha Pandit 78650.0 (0.04%) Shareholding of Promoter and Promoter Group
Anand Y Pandit 9920.0 (0.01%) Shareholding of Promoter and Promoter Group
Mk Falcon Agro Tech Pvt. Ltd. 0.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

CAMLIN FINE SCIENCES LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
28 Jul 2016 0.45 Final 01 Aug 2016 Equity shares
27 Jul 2015 0.45 Final 29 Jul 2015 Equity shares
24 Jul 2014 0.7 Final 28 Jul 2014 Equity shares
01 Aug 2013 0.6 Final 05 Aug 2013 Equity shares
23 Jul 2012 0.5 Final 25 Jul 2012 Equity shares
20 Jul 2011 2.0 Final 22 Jul 2011 Equity shares
22 Jun 2010 2.0 Final 24 Jun 2010 Equity shares
12 Aug 2009 1.5 Final 14 Aug 2009 Equity shares
30 Jul 2008 1.0 Final 01 Aug 2008 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
04 Sep 2014 2.0 1.0 05 Sep 2014
15 Feb 2012 10.0 2.0 17 Feb 2012
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
28 Jul 2016 0.45 Final 01 Aug 2016 Equity shares
27 Jul 2015 0.45 Final 29 Jul 2015 Equity shares
24 Jul 2014 0.7 Final 28 Jul 2014 Equity shares
01 Aug 2013 0.6 Final 05 Aug 2013 Equity shares
23 Jul 2012 0.5 Final 25 Jul 2012 Equity shares
20 Jul 2011 2.0 Final 22 Jul 2011 Equity shares
22 Jun 2010 2.0 Final 24 Jun 2010 Equity shares
12 Aug 2009 1.5 Final 14 Aug 2009 Equity shares
30 Jul 2008 1.0 Final 01 Aug 2008 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
04 Sep 2014 2.0 1.0 05 Sep 2014
15 Feb 2012 10.0 2.0 17 Feb 2012

CAMLIN FINE SCIENCES LTD Share Price

Camlin Fine Sciences Limited was originally incorporated on November 30, 1993 as a Private Limited Company with the name of 'Camlicon Consultants Private Limited'. On June 1, 2006, the Company name was changed from Camlicon Consultants Private Limited to Camlin Fine Chemicals Private Limited. As per the Scheme of Arrangement, the Fine Chemicals Division of Camlin Limited got demerged and transferred to the Company effective from July 01, 2006. On August 11, 2006, the Company status was converted into Public Limited Company and the name was changed to Camlin Fine Chemicals Limited. W.e.f. 27th August, 2011 name of the Company was changed from Camlin Fine Chemicals Limited to Camlin Fine Sciences Limited.

The Company is one of the India's leading manufacturers and exporters of Bulk Drugs, Fine Chemicals and Food Grade products. It manufactures active pharmaceutical ingredients (API's), food antioxidants and sweeteners. They operate in two business divisions, namely Food Ingredients Division and Industrial products Division. The company's products have applications in processed foods, edible oils, paints, polymers, alternative fuels (biodiesel), rubber, health, and pharmaceuticals.

The company has a strong research and development which is focused on bringing in continual improvements on process and products, backward integration and developing innovative products. The research and development is equipped with comprehensive and updated instrumentation for conducting quality analysis, stability studies. The research and development also is equipped to conduct application studies on stability index of edible oils and Bio-diesel.

In April 2006, the main object of the Company was altered to enable the Company to pursue business in Fine Chemicals. They launched a new product namely, 'Sucralose' which is a synthetic sweetener with large demand and attractive price.

The company entered into a joint venture with Viachem LLC USA on 51:49 basis and set up a company namely, Dulcette Technologies LLC for marketing Sucralose, Aspartame and Acesulfame-K and their blends in USA, Canada and Mexico. In March 30, 2007, the equity shares of the company were listed on the Bombay Stock Exchange (BSE).

During the year 2007-08, the company increased the production capacity of Chemical & Chemical Products from 1,636 Ltrs/Kgs to 2,476 Ltrs/Kgs. The company acquired the control of Sangam Laboratories Ltd by acquiring 60% of the paid up equity share capital of the company. They invested Rs 5 lakh for controlling interest in the Equity Share Capital of Chemolutions Chemicals Ltd.

In February 2008, the company entered into a joint venture agreement with Advanced Aerospace Technologies Inc., USA' to manufacture and market speciality fine chemicals primarily to cater to European and U.S markets. During the year 2008-09, the company expanded the production capacity of Chemical & Chemical Products from 2,476 Ltrs/Kgs to 2,548 Ltrs/Kgs. The company invested Rs 25.50 lakh in Fine Lifestyle Brands Ltd and Rs.5.10 lakh in Fine Renewable Energy Ltd, which represents 51% of equity share capital of each of them. They further invested Rs 92.32 lakh in the share capital of their present subsidiaries, namely Sangam Laboratories Ltd, Chemolutions Chemicals Ltd and Dulcette Technologies LLC, USA.

During the year 2009-10, the company expanded the production capacity of Chemical & Chemical Products from 2,458 Ltrs/Kgs to 3,500 Ltrs/Kgs. They are entering the field of Bio technology products and first patented, biotechnology based Natural shelf life enhancing formula for increasing shelf life of Natural farm produce, like fruits, vegetables and flowers.

During the year 2011, Chemolutions Chemicals Limited, Fine Lifestyle Brands Limited and Fine Renewable Energy Limited ceased to be subsidiaries of the Company. The Hon'ble High Court Bombay, vide order dated 21st April, 2011 approved Scheme of Amalgamation for merger of Sangam Laboratories Limited, a 100% owned subsidiary with the Company.

The establishment of two major business divisions, namely, Food and Industrial Products was completed. The Company expanded its manufacturing capacity of the food antioxidants, Ascorbyl Palmitate, TBHQ and BHA in 2012-13. In January 2016, it started operations in Central America with the launch of CFS Antioxidantes De Mexico, S.A. de C.V., a 100% subsidiary of Camlin Fine Sciences Ltd., acquired 65% stake in Dresen Química S.A.P.I de C.V, a leading food and feed blend company in Mexico; launched CFS North America, LLC, a 100% owned subsidiary of CFS for manufacturing and selling of customised antioxidant blends; launched Evanil, ethyl vanillin for food and bakery industry.

On 15th April, 2016, a 100% wholly owned subsidiary CFS International Trading (Shanghai) Ltd. was incorporated in China (Shanghai) pilot free trade zone to manufacture and deal in speciality chemicals. On 22nd March, 2017, Chemolutions Chemicals Limited (CCL) allotted 62,67,003 equity shares on preferential basis to the Company. Post allotment, the shareholding of Company in CCL was 94.08% and CCL became the subsidiary of the Company. In July 2017, Company through its wholly owned stepdown subsidiary viz. CFS Europe S.p.A. acquired 51% stake in CFS Wanglong Flavours (Ningbo) Co. Ltd. erstwhile Ningbo Wanglong Flavors and Fragrances Company Limited. In April 2018, Company signed a joint venture contract with Pahang Pharma (S) Pte. Ltd., Singapore (Pahang) for incorporating a holding company, shareholding in the proportion of 51:49, named CFS Pahang Asia Pte. Ltd. in Singapore.

In 2019, the Company reverse merged its wholly owned subsidiary in Mauritius viz., CFCL Mauritius Private Limited into CFS Europe Spa, Italy effective 25th June, 2019 and resultant to this merger, CFS Europe Spa became a wholly-owned subsidiary. The reverse merger of CFS Antioxidnates De Mexico De CV with Dresen Quimica SAPI De CV was effective 31st January, 2019 and resultant to reverse merger, CFS Antioxidantes De Mexico S.A. de. C.V. ceased to be the wholly-owned subsidiary of the Company from the aforementioned date. As a part of this initiative, Company acquired a company situated in Southern part of India, namely, AlgalR Nutrapharms Private Limited (AlgalR) which manufactures oils containing Omega 3 Fatty Acids. The company embarked upon its largest greenfield expansion in 2018 in Dahej, Gujarat for a green-technology-based DiPhenol plant for a 10,000 MT Di-Phenol facility. And in September 2020, it announced the commercial production of Hydroquinone and Catechol.

During the financial year 2021-22, AlgalR NutraPharms Private Limited and CFS De Mexico Blends SAPI De CV became subsidiaries and Fine Lifestyle Brands Limited has ceased to be a Associate of the Company.

The Company initiated the commercial production of Vanillin and Ethyl Vanillin in Dahej in January, 2023 in FY 2023-24.

Parent organization Indian Private
NSE symbol CAMLINFINE
Founded 1993
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Camlin Fine Sciences Ltd?

Answer Field

Camlin Fine Sciences Ltd share price is for NSE ₹ 313.80 & for BSE ₹ 315.00 as on Jun 30 2025 03:30 PM.

What is the Market Cap of Camlin Fine Sciences Ltd Share?

Answer Field

The market cap of Camlin Fine Sciences Ltd for NSE ₹ 5,255.05 & for BSE ₹ 5,275.15 as on Jun 30 2025 03:30 PM.

What is the 52 Week High and Low of Camlin Fine Sciences Ltd?

Answer Field

The 52 Week High and Low of Camlin Fine Sciences Ltd for NSE is ₹ 333.30 and ₹ 93.40 and for BSE is ₹ 334.70 and ₹ 93.59.

What is 1 year return for Camlin Fine Sciences Ltd?

Answer Field

The 1 year returns on the stock has been 221.61%.

What is the P/E Ratio of Camlin Fine Sciences Ltd Share?

Answer Field

As on Jun 30 2025 03:30 PM the price-to-earnings (PE) ratio for Camlin Fine Sciences Ltd share is -78.44.

What is the PB ratio of Camlin Fine Sciences Ltd Share?

Answer Field

As on Jun 30 2025 03:30 PM, the price-to-book (PB) ratio for Camlin Fine Sciences Ltd share is 45.88.

How to Buy Camlin Fine Sciences Ltd Share?

Answer Field

You can trade in Camlin Fine Sciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Camlin Fine Sciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Camlin Fine Sciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Camlin Fine Sciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|